TikTok's 'top 3 peptides for summer' trend: what the science says

What did @dan.hayes.peps actually say?

The creator pitched three peptides as a summer appearance stack: GHK-Cu for skin, hair, and nails, melanotan I or II for a tan, and an unnamed GLP-1 receptor agonist he describes as "the famous GLP that starts with the letter R." He framed these as self-evident choices, saying the third one "comes without question that everybody will probably be on to this." He avoided naming semaglutide directly, presumably because platform rules restrict it.

To be clear about what he claimed: GHK-Cu will make you "look ten times better," melanotan II delivers a "fake tan" that is "a lot stronger," and the unnamed GLP-1 drug is so mainstream it barely needs explaining. That is the full claim set. No dosing, no mechanism, no safety caveats.

Does the science back this up?

For GHK-Cu, the evidence is genuinely interesting but mostly preclinical. For melanotan II, the evidence is real but the risk profile is not trivial. For semaglutide, the weight-loss evidence is among the strongest in modern metabolic medicine. The problem is none of these are equivalent claims.

GHK-Cu has shown collagen-stimulating activity in cell studies and some small human trials. Pickart and Margolina (2018, Biomolecules) reviewed copper peptide research and noted effects on skin remodeling and wound healing, but acknowledged most data comes from in vitro or animal models. Human skin trials exist but are small and often funded by cosmetic industry players. Hair growth data in humans is sparse. Nails? Almost no published clinical data at all.

Melanotan II activates MC1R and MC4R receptors. The tanning effect is real. So is the nausea, spontaneous erection in men, and the fact that it remains unlicensed in most markets. Melanotan I (afamelanotide) is actually approved in some countries for erythropoietic protoporphyria, which is a different use case entirely. Lumping them together as a casual "fake tan" option glosses over a meaningful difference in safety profiles.

What did they get wrong (or right)?

He got the GHK-Cu skin framing mostly right in direction, even if he overstated certainty. The peptide does have biological plausibility for skin support. Saying it will make you "look ten times better" is marketing language, not science, but the underlying mechanism is not invented.

Where he goes wrong is melanotan II. Describing it simply as giving you "a fake tan" and being "a lot stronger" skips over a documented safety concern: unregulated melanotan II is often sold as gray-market research chemical, purity is unverified, and the MC4R agonism drives systemic effects beyond skin pigmentation. A 2009 paper by Breit et al. in the British Journal of Dermatology flagged concerns about melanocytic lesion changes in users. That is not a minor footnote.

The GLP-1 drug framing is the most problematic. Calling semaglutide a peptide you take to "look fucking good for the beach" strips out the clinical context entirely. It is an approved medication for type 2 diabetes and obesity, not a cosmetic tool. Using it outside medical supervision carries real risks including pancreatitis, muscle mass loss, and severe gastrointestinal events.

What should you actually know?

These three compounds sit in very different regulatory and evidence categories, and treating them as a casual aesthetic stack is misleading. GHK-Cu is the most defensible for topical or low-risk peptide use, with a reasonable mechanistic rationale and no serious adverse event profile in the literature. Melanotan II is the most problematic: unlicensed, with systemic receptor activity and real safety signals. Semaglutide is a legitimate medical intervention being casually name-dropped as a beach prep tool.

If you are considering any of these, the relevant questions are not "which gives me the best summer look" but rather: is this compounded or pharmaceutical grade, who is supervising your use, and what is the actual risk-benefit for your health profile. A telehealth provider or physician who reviews your bloodwork and history is the appropriate starting point, not a TikTok stack recommendation. GHK-Cu via a regulated peptide protocol is a reasonable conversation to have with a clinician. Melanotan II outside a licensed clinical context is a different matter entirely. And semaglutide requires a prescribing physician, period.